HBio Capital Management is a venture capital firm dedicated to investing in pioneering biotechnology companies. The firm focuses on identifying and supporting enterprises that are developing transformative medicines and technologies to address significant unmet medical needs. Their strategy involves backing innovative science and strong management teams from early stages through to commercialization, aiming to generate both significant financial returns and a lasting impact on human health.

Founded in

Switzerland